CSB 2.009 Note
(2) Paragraphs (m) and (n) of sub. (3), s.
161.18, Stats., schedule III, are hereby created to read as follows:
CSB 2.009 Note
(m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CSB 2.009 Note
(n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
CSB 2.009 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.009 Note
CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s.
161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
CSB 2.009 Note
(hm) Drotebanol;
CSB 2.009 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.009 Note
CSB 2.06 Addition of pentazocine to schedule III. Subsection
(4m) of s.
161.18, Stats., schedule III is hereby created to read as follows:
CSB 2.009 Note
(4m) Pentazocine.
CSB 2.009 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.009 Note
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection
(3) (intro.) of s.
161.14, Stats., schedule I is amended to read:
CSB 2.009 Note
(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.009 Note
(2) Paragraph (em) of sub. (3), s.
161.16, Stats., schedule II, is hereby created to read:
CSB 2.009 Note
(em) Etorphine hydrochloride;
CSB 2.009 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.009 Note
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s.
161.16, Stats., schedule II is hereby created to read:
CSB 2.009 Note
(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.009 Note
(2) Paragraph
(n) of sub.
(2) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(n) Mebutamate
CSB 2.009 Note
(3) Paragraph
(b) of sub.
(2m) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(b) Pemoline:
CSB 2.009 History
History:
Cr.
Register, February, 1976, No. 242, eff. 3-1-76.
CSB 2.009 Note
CSB 2.09 Additions to schedules IV and I. (1)
Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s.
161.20, Stats., schedule IV are hereby created to read:
CSB 2.009 Note
(cm) Chlordiazepoxide
CSB 2.009 Note
(cn) Clonazepam
CSB 2.009 Note
(cp) Chlorazepate
CSB 2.009 Note
(cr) Diazepam
CSB 2.009 Note
(em) Flurazepam
CSB 2.009 Note
(hm) Oxazepam
CSB 2.009 Note
(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.009 Note
(u) Thiophene analog of phencyclidine
CSB 2.009 Note
(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s.
161.14, Stats., schedule I are hereby created to read:
CSB 2.009 Note
(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
CSB 2.009 Note
(a) Mecloqualone
CSB 2.009 Note
(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.009 Note
(hg) Difenoxin
CSB 2.009 Note
(5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s.
161.14, Stats., schedule I are hereby created to read:
CSB 2.009 Note
(v) 2,5-dimethoxyamphetamine
CSB 2.009 Note
(w) 4-bromo-2,5-dimethoxyamphetamine
CSB 2.009 Note
(x) 4-methoxyamphetamine
CSB 2.009 History
History:
Cr.
Register, April, 1976, No. 244, eff. 5-1-76.
CSB 2.009 Note
CSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.009 Note
(wn) Propiram
CSB 2.009 History
History:
Cr.
Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.009 Note
CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.009 Note
(b) Fenfluramine
CSB 2.009 Note
Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.009 Note
(a) Diethylpropion
CSB 2.009 Note
Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.009 Note
(c) Pemoline
CSB 2.009 NoteParagraph (d) of sub. (2m), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(d) Phentermine
CSB 2.009 History
History:
Cr.
Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.009 Note
CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
CSB 2.009 Note
(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
CSB 2.009 History
History:
Cr.
Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.009 Note
CSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(km) Prazepam
CSB 2.009 History
History:
Cr.
Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.009 Note
CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s.
161.14, Stats., is created to read:
CSB 2.009 Note
(mn) Parahexyl
CSB 2.009 Note
(2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
CSB 2.009 Note
(3) Paragraph (nm) of sub. (2), s.
161.20, Stats., is created to read:
CSB 2.009 Note
(nm) Triazolam
CSB 2.009 History
History:
Cr.
Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.009 Note
CSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.
CSB 2.009 Note
(2) Section
161.16 (3) (y), Stats., is created to read:
CSB 2.009 Note
(y) Sufentanil
CSB 2.009 History
History:
Cr.
Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.009 Note
CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s.
161.14 (5), Stats., is adopted to read:
CSB 2.009 Note
(b) Methaqualone
CSB 2.009 Note
(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.
CSB 2.009 Note
(4) Subsection
(10) (a) of s.
161.16, Stats., is created to read:
CSB 2.009 Note
(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
CSB 2.009 History
History:
Cr.
Register, August, 1986, No. 368, eff. 9-1-86;
CR 03-056: r. (1)
Register January 2004 No. 577, eff. 2-1-04.
CSB 2.009 Note
CSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(am) 3, 4-methylenedioxymethamphetamine, commonly known as“MDMA";
CSB 2.009 History
History:
Cr.
Register, September, 1987, No. 381, eff. 10-1-87.
CSB 2.009 Note
CSB 2.19 Additions, deletions and transfers to statutory schedules. (1) Paragraph (b) of s.
161.20 (4), Stats., is created to read:
CSB 2.009 Note
(b) Not more than 25 milligrams per dosage unit of pentazocine with one or more active, non-narcotic ingredients in recognized therapeutic amounts.
CSB 2.009 Note
(2) Paragraph (b) of s. 161.18 (4), Stats., is repealed.
CSB 2.009 Note
(3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
